Trinity Biotech PLC

TRIB

Exchange: Nasdaq
Industry: In Vitro & In Vivo Diagnostic Substances
SEC CIK: 0000888721

SEC filings (opens in a new tab)

No open-market purchases or sales by Trinity Biotech PLC insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $379.5K in total; no superinvestor holds it.

Q1 2022 vs. Q4 2021

How the institutions holding Trinity Biotech PLC changed between Q4 2021 and Q1 2022.

All holders in Q1 2022 All holders in Q4 2021

13F holders of TRIB: Q4 2021 compared with Q1 2022
Measure	Q4 2021	Q1 2022	Change
Holders	21	22	+1
Shares	5.39M	9.02M	+3.63M (+67.3%)
Value	$7.70M	$9.56M	+$1.86M (+24.1%)

New holders (3)

Institutions that held Trinity Biotech PLC at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to TRIB in Q1 2022
Institution	Shares	Value	% of portfolio
Highbridge Capital Management LLC	1,151,610	$1.22M	0.03%
Virtu Financial LLC	37,926	$40.0K	0.00%
Atria Wealth Solutions, Inc.	25,500	$27.0K	0.00%

Sold out (2)

Institutions that held Trinity Biotech PLC at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of TRIB in Q1 2022
Institution	Shares, Q4 2021	Value, Q4 2021
Citadel Advisors LLC	18,884	$27.0K
Simplex Trading, LLC	7,498	$10.0K